FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients.

Br J Cancer · 2019 · PMC6889357 · PMID 31434988

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Both approaches identified ECM-receptor interaction pathway as highly significant (hypergeometric test FDR = 5.37E-07, SPIA FDR = 2.3E-07).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.